ABSTRACT We investigated the incidence of hepatitis B (HBV) and C (HCV) virus infection among patients with liver disease in Qatar from 2000 to 2005. The grading and staging of HBV and HCV cases were obtained from pathology reports at the principal reference laboratory for Qatar. Of the 915 liver patients studied, 29.4% had HCV and 2.5% had HBV. The incidence of HBV and HCV infection was greater in non-Qataris than Qatari nationals and in males than females, especially for HCV. Most cases were uncomplicated (89.0%) and had no inflammation (76.4%). The incidence of HCV has been increasing in liver patients in recent years up to a rate of 481 per 1000 patients with liver disease in 2005. 
Introduction
Hepatitis is an infection of the liver caused by several viruses, the most common of which are hepatitis A, B and C. Both hepatitis B virus (HBV) and C virus (HCV) are spread mainly through contaminated blood and blood products, sexual contact and contaminated needles. Although there has been a decrease in the incidence of viral hepatitis over the last decade, it is still the most common cause of chronic liver disease worldwide [1] [2] [3] [4] [5] . Globally, the number of individuals infected with HBV has been estimated to be 350 million, 40% of whom may progress to cirrhosis, liver failure and hepatocellular carcinoma [3] . Approximately 170 million people worldwide are affected with HCV. It is the most common chronic infection in the United States of America (USA) and is responsible for 40% of chronic liver disease [4] . HCV infections are the principal cause of chronic liver disease, cirrhosis, carcinoma and liver transplantation. Over 17 000 people with chronic liver disease were listed for liver transplantation in 2003, with > 10% expected to die before the operation [6] .
Although viral hepatitis is a global health problem, there is a considerable variability in HBV and HCV rates between and within countries and between ethnic groups [2] . The aim of this study was to assess the incidence and impact of HBV and HCV infection in patients with liver disease in Qatar.
Methods
This was a cohort hospital-based study in Qatar during the period 2000-05.
Information was gathered from the hepatitis disease registry of the Department of Preventive Medicine in the National Health Authority. Details of any patient who visits a primary health centre or private clinic in Qatar with symptoms and signs of hepatitis are notified to the Communicable Diseases Control Section and a blood specimen is sent to the central laboratory of the Hamad Medical Corporation for diagnostic tests. All reports of positive cases from the laboratory are forwarded to the Communicable Diseases Control Section database, thus ensuring that any hepatitis patient in Qatar is accurately documented.
All infectious diseases reported to the Department of Preventive Medicine are coded according to the International statistical classification of diseases and related health problems (ICD-10). Viral hepatitis is classified into acute hepatitis A (B15), acute hepatitis B (B16), other acute viral hepatitis (B17), chronic viral hepatitis (B-18) and unspecified viral hepatitis (B-19) [7] . In the Qatar central laboratory, all cases of acute and chronic viral hepatitis B are classified under B-16 and acute and chronic viral hepatitis C are classified under B-18.
From a total of 915 patients in Qatar with hepatitis documented over the study period, we studied all patients with HBV and HCV infection. Liver biopsy of the studied patients helped to establish the correct diagnosis, assess the histological activity (grading) and assess structural changes, including fibrosis and cirrhosis (staging).
Histological study of liver biopsies was performed in the histopathology laboratory at Hamad General Hospital. Differentiation between chronic HBV and HCV infection was based on the presence of classical ground-glass hepatocytes and positive staining for hepatitis B surface antigen in cases of HBV infection. Cases of chronic hepatitis C showed some or all of the histological features usually present in this infection, including lymphoid follicles in portal tracts, damaged interlobular bile ducts, steatosis and granulomas.
٢٠٠٩ ،٤ ‫ﺍﻟﻌﺪﺩ‬ ‫ﻋﴩ،‬ ‫ﺍﳋﺎﻣﺲ‬ ‫ﺍﳌﺠﻠﺪ‬ ‫ﺍﻟﻌﺎﳌﻴﺔ،‬ ‫ﺍﻟﺼﺤﺔ‬ ‫ﻣﻨﻈﻤﺔ‬ ‫ﺍﳌﺘﻮﺳﻂ،‬ ‫ﻟﴩﻕ‬ ‫ﺍﻟﺼﺤﻴﺔ‬ ‫ﺍﳌﺠﻠﺔ‬
The histological changes of chronic hepatitis were classified according to the method of Scheuer [8] . The grading score (0-4) represents necroinflammatory activity, from absent or minimal (0) to severe and widespread interface hepatitis (4). The staging score (0-4) is based on the degree and extent of fibrosis, from no fibrosis (0) to probable or definite cirrhosis (4).
The chi-squared test for trend was used to compare the trend statistical significance differences between years. P < 0.05 was taken as the cut-off value for significance.
Results
Of the 915 patients with liver disease who were screened during the period 2000-05, 269 (29.4%) had HCV and 23 (2.5%) had HBV infection. Figure 1 shows the incidence of HBV and HCV infection per 1000 population with liver disease over each year of the study. In every year, HCV was more common than HBV. However, there was a no- Over the years, the rate of HBV and HCV infection was higher in male than female patients (73.9% versus 26.1% for HBV and 80.7% versus 19.3% for HCV) ( Table 2) . Table 3 shows the stage and grade of HBV and HCV in the patients by nationality. Most of the cases were uncomplicated (260, 89.0%) and had no inflammation (233, 76.4%). Of the complicated cases (32 patients), stage 2 was frequent (10 cases), especially in those of non-Qatari nationality (7 patients). Also, among patients with inflammation, grade 2 was the most frequent (38 cases), of whom 32 were non-Qataris.
Comparing the proportion of HBV and HCV among patients with liver disease in studies from different countries (Table 4) , the proportion of HCV in Qatar (29.4%) and Pakistan (29.0%) were similar and very close to the proportion of India (31.5%). HBV, on the other hand, is relatively rare in Qatar (2.5%) and incidence was relatively lower than in the USA and the Far East.
Discussion
Viral hepatitis is the most common cause of chronic liver disease throughout the world [9, 10] . Chronic HBV accounts for 5%-10% of cases of chronic liver disease and cirrhosis in the USA [9] . In our study, 31.9% of patients with liver disease had HCV or HBV. A study in Singapore showed that chronic HCV-and HBV-related liver disease constituted 57% of all indications for adult liver transplants [11] . A study in Romania on chronic HCV and HBV infections showed that an association with chronic liver disease was seen in half the patients [12] . 
٢٠٠٩ ،٤ ‫ﺍﻟﻌﺪﺩ‬ ‫ﻋﴩ،‬ ‫ﺍﳋﺎﻣﺲ‬ ‫ﺍﳌﺠﻠﺪ‬ ‫ﺍﻟﻌﺎﳌﻴﺔ،‬ ‫ﺍﻟﺼﺤﺔ‬ ‫ﻣﻨﻈﻤﺔ‬ ‫ﺍﳌﺘﻮﺳﻂ،‬ ‫ﻟﴩﻕ‬ ‫ﺍﻟﺼﺤﻴﺔ‬ ‫ﺍﳌﺠﻠﺔ‬
In Singapore the prevalence of HBVrelated liver diseases was high (Table 4) , which was not surprising as HBV is endemic with a 4.1% carrier rate and complication developing in 10%-40% of patients with chronic HBV [11] . In Qatar, HBV was relatively rare, 2.5%, HCV was more common in patients with liver disease (29.4%) and the incidence increased throughout the study period. In contrast, HCV is relatively rare in Singapore and in parts of Asia [13] . In addition, studies from India have shown a prevalence of HCV of 3%-31.5% in patients with cirrhosis and chronic liver disease (Table 4 ) [14] . However, clinical studies from southern Europe and the USA have shown a high percentage of HCV infection in patients with cirrhosis [15] , which is consistent with our findings.
There is considerable variability in the prevalence of HBV and HCV between different countries and ethnic groups. For instance, the prevalence of HCV in people with chronic liver disease has been estimated at 62%-74% in Italy [16] , 74% in Egypt [17] and only 29% in Pakistan [18] . This is similar to our finding that non-Qatari liver patients had a higher rate of HBV and HCV infection than Qatari liver patients. People of nonQatari nationality in Qatar come mostly from hepatitis-endemic areas, which explains the higher incidence among them. 
It is evident from the study findings that HCV is a major cause of chronic liver disease in Qatar. Poynard, Bedossa and Opolon reported that approximately 300 million people infected worldwide with HCV will progress to cirrhosis or liver failure, and would need a transplant in the future [19] .
Conclusion
The present study findings revealed that over 30% of patients in Qatar with liver disease had viral HBV or HCV, with HCV playing the greater role,. HBV and HCV infection are both preventable. In order to limit the spread of hepatitis, efforts must be directed at minimizing exposure to sources of infection. Further studies are necessary to evaluate the sociodemographic and other associated risk factors involved with HBV and HCV infection in patients with liver disease.
